Janssen Cilag S.A.S. clinical trials

A country office of Johnson & Johnson

The registry lists 8 studies whose lead sponsor is Janssen Cilag S.A.S.. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 25, 2026.

Studies

Recruiting first, then most recently updated. Showing 8 of 8. All Johnson & Johnson studies →

• Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic LeukemiaRecruitingNCT06299540

  Sponsor listed in the registry: Janssen Cilag S.A.S.

• A Study to Assess Adherence to Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer Participants in FranceRecruitingNCT07451002

  Sponsor listed in the registry: Janssen Cilag S.A.S.

• Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory DiseasesCompletedNCT03606499

  Sponsor listed in the registry: Janssen Cilag S.A.S.

• A Study to Characterize Profile of Participant With Psoriatic Arthritis Depending on Whether Their Disease is Managed by a Dermatologist or by a Rheumatologist, and Starting UstekinumabCompletedNCT03336281

  Sponsor listed in the registry: Janssen Cilag S.A.S.

• Influence of Rabeprazole on the Magnitude of the Antiplatelet Action of ClopidogrelCompletedNCT00989300Phase 1

  Sponsor listed in the registry: Janssen Cilag S.A.S.

• Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer PainTerminatedNCT00236327Phase 4

  Sponsor listed in the registry: Janssen Cilag S.A.S.

• Effects of Early Correction of Anemia in Patients With Chronic Renal InsufficiencyTerminatedNCT00312871Phase 4

  Sponsor listed in the registry: Janssen Cilag S.A.S.

• Effect of Early High-dose Epoetin Alfa During Cardiac Arrest (Pilot Study)CompletedNCT00719498Phase 3

  Sponsor listed in the registry: Janssen Cilag S.A.S.